메뉴 건너뛰기
.. 내서재 .. 알림
소속 기관/학교 인증
인증하면 논문, 학술자료 등을  무료로 열람할 수 있어요.
한국대학교, 누리자동차, 시립도서관 등 나의 기관을 확인해보세요
(국내 대학 90% 이상 구독 중)
로그인 회원가입 고객센터 ENG
주제분류

추천
검색

논문 기본 정보

자료유형
학술저널
저자정보
저널정보
대한암학회 Cancer Research and Treatment Cancer Research and Treatment 제47권 제1호
발행연도
2015.1
수록면
90 - 100 (11page)

이용수

표지
📌
연구주제
📖
연구배경
🔬
연구방법
🏆
연구결과
AI에게 요청하기
추천
검색

초록· 키워드

오류제보하기
Purpose Non-steroidal anti-inflammatory drugs (NSAIDs) and statins are potential chemopreventiveor chemotherapeutic agents. The mechanism underlying the deregulation of survivin byNSAIDs and statins in human non-small cell lung cancer cells has not been elucidated. Inthis study, we investigated the synergistic interaction of sulindac and simvastatin in lungcancer A549 cells. Materials and MethodsCell viability was measured by an MTT assay, while the expression of apoptotic markers,AKT, and survivin in response to sulindac and simvastatin was examined by Westernblotting. DNA fragmentation by apoptosis was analyzed by flow cytometry in A549 cells. Reactive oxygen species (ROS) generation was measured by flow cytometry using H2DCFDAand MitoSOX Red, and the effects of pretreatment with N-acetylcysteine were tested. Theeffects of AKT on survivin expression in sulindac- and simvastatin-treated cells wereassessed. Survivin was knocked down or overexpressed to determine its role in apoptosisinduced by sulindac and simvastatin. ResultsSulindac and simvastatin synergistically augmented apoptotic activity and intracellular ROSproduction in A549 cells. Inhibition of AKT by siRNA or LY294002 inhibited survivin, whileAKT overexpression markedly increased survivin expression, even in the presence ofsulindac and simvastatin. Moreover, survivin siRNA enhanced sulindac- and simvastatininducedapoptosis. In contrast, survivin upregulation protected against sulindac- andsimvastatin-induced apoptosis. ConclusionCombined treatment with sulindac and simvastatin augmented their apoptotic potential inlung cancer cells through AKT signaling-dependent downregulation of survivin. These resultsindicate that sulindac and simvastatin may be clinically promising therapies for the preventionof lung cancer.

목차

등록된 정보가 없습니다.

참고문헌 (24)

참고문헌 신청

함께 읽어보면 좋을 논문

논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!

이 논문의 저자 정보

최근 본 자료

전체보기

댓글(0)

0